APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Belladonna Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Belladonna Tablets Industry Growth and Trends Forecast to 2032

Report ID 173969630128 December 2025125 pages

Choose your research edition.

Industry ResearchBelladonna Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Belladonna Tablets Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Belladonna Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Belladonna Tablets Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Belladonna Tablets Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Belladonna Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Belladonna Tablets include Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd., Yangzhou Aidi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Wanbangde Pharmaceutical Group Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd., Shenyang Tonglian Pharmaceutical Co., Ltd., Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd., Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. and Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Belladonna Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Belladonna Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Belladonna Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Belladonna Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Belladonna Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Belladonna Tablets Market by Company

Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.

Yangzhou Aidi Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Wanbangde Pharmaceutical Group Co., Ltd.

CSPC Ouyi Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.

Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.

Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.

Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.

Jilin Luwang Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Jilin Daojun Pharmaceutical Co., Ltd.

Henan Baiquan Pharmaceutical Co., Ltd.

Sinopharm Xinjiang Pharmaceutical Co., Ltd.

Guangxi Dahaiguang Pharmaceutical Co., Ltd.

Gansu Lanyao Pharmaceutical Co., Ltd.

Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.

Aimin Pharmaceutical Group Co., Ltd.

Weleda

Raritan Pharmaceuticals

Hyland's Inc

Belladonna Tablets Segment by Type

Compound Preparations

Single Preparations

Belladonna Tablets Segment by Application

Hospital

Clinic

Other

Belladonna Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Belladonna Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Belladonna Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Belladonna Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Belladonna Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Belladonna Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Compound Preparations Table 2. Major Company of Single Preparations Table 3. Global Belladonna Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Belladonna Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Belladonna Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Belladonna Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Belladonna Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Belladonna Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Belladonna Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Belladonna Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Belladonna Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Belladonna Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Belladonna Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Belladonna Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Belladonna Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Belladonna Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Belladonna Tablets Industry Trends Table 25. Belladonna Tablets Industry Drivers Table 26. Belladonna Tablets Industry Opportunities and Challenges Table 27. Belladonna Tablets Industry Restraints Table 28. Global Belladonna Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Belladonna Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Belladonna Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Belladonna Tablets Sales Share by Company (2021-2026) Table 32. Global Belladonna Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Belladonna Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Belladonna Tablets Major Company Production Sites and Headquarters Table 35. Global Belladonna Tablets Company, Product Type & Application Table 36. Global Belladonna Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Belladonna Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Belladonna Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Belladonna Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Belladonna Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Belladonna Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Belladonna Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Belladonna Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Belladonna Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Belladonna Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Belladonna Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Belladonna Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Belladonna Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Belladonna Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Belladonna Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Belladonna Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Belladonna Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Belladonna Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Belladonna Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Belladonna Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Belladonna Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Belladonna Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Belladonna Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Belladonna Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Belladonna Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information Table 72. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview Table 73. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio Table 75. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Development Table 76. Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information Table 77. Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview Table 78. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 80. Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Development Table 81. Southwest Pharmaceutical Co., Ltd. Company Information Table 82. Southwest Pharmaceutical Co., Ltd. Business Overview Table 83. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 85. Southwest Pharmaceutical Co., Ltd. Recent Development Table 86. Wanbangde Pharmaceutical Group Co., Ltd. Company Information Table 87. Wanbangde Pharmaceutical Group Co., Ltd. Business Overview Table 88. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 90. Wanbangde Pharmaceutical Group Co., Ltd. Recent Development Table 91. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information Table 92. CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview Table 93. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 95. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development Table 96. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 97. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 98. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 100. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 101. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information Table 102. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview Table 103. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 105. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Development Table 106. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information Table 107. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview Table 108. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 110. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Development Table 111. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information Table 112. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview Table 113. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 115. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Development Table 116. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information Table 117. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview Table 118. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio Table 120. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Development Table 121. Jilin Luwang Pharmaceutical Co., Ltd. Company Information Table 122. Jilin Luwang Pharmaceutical Co., Ltd. Business Overview Table 123. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 125. Jilin Luwang Pharmaceutical Co., Ltd. Recent Development Table 126. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 127. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 128. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 130. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 131. Jilin Daojun Pharmaceutical Co., Ltd. Company Information Table 132. Jilin Daojun Pharmaceutical Co., Ltd. Business Overview Table 133. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 135. Jilin Daojun Pharmaceutical Co., Ltd. Recent Development Table 136. Henan Baiquan Pharmaceutical Co., Ltd. Company Information Table 137. Henan Baiquan Pharmaceutical Co., Ltd. Business Overview Table 138. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 140. Henan Baiquan Pharmaceutical Co., Ltd. Recent Development Table 141. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information Table 142. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview Table 143. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 145. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Development Table 146. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information Table 147. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview Table 148. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 150. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Development Table 151. Gansu Lanyao Pharmaceutical Co., Ltd. Company Information Table 152. Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview Table 153. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 155. Gansu Lanyao Pharmaceutical Co., Ltd. Recent Development Table 156. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information Table 157. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 158. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 160. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 161. Aimin Pharmaceutical Group Co., Ltd. Company Information Table 162. Aimin Pharmaceutical Group Co., Ltd. Business Overview Table 163. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 165. Aimin Pharmaceutical Group Co., Ltd. Recent Development Table 166. Weleda Company Information Table 167. Weleda Business Overview Table 168. Weleda Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Weleda Belladonna Tablets Product Portfolio Table 170. Weleda Recent Development Table 171. Raritan Pharmaceuticals Company Information Table 172. Raritan Pharmaceuticals Business Overview Table 173. Raritan Pharmaceuticals Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Raritan Pharmaceuticals Belladonna Tablets Product Portfolio Table 175. Raritan Pharmaceuticals Recent Development Table 176. Hyland's Inc Company Information Table 177. Hyland's Inc Business Overview Table 178. Hyland's Inc Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Hyland's Inc Belladonna Tablets Product Portfolio Table 180. Hyland's Inc Recent Development Table 181. North America Belladonna Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. North America Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 183. North America Belladonna Tablets Sales Market Share by Country (2021-2026) Table 184. North America Belladonna Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 185. North America Belladonna Tablets Sales Market Share Forecast by Country (2027-2032) Table 186. North America Belladonna Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. North America Belladonna Tablets Market Size by Country (2021-2026) & (US$ Million) Table 188. North America Belladonna Tablets Market Share by Country (2021-2026) Table 189. North America Belladonna Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. North America Belladonna Tablets Market Share Forecast by Country (2027-2032) Table 191. Europe Belladonna Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Europe Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 193. Europe Belladonna Tablets Sales Market Share by Country (2021-2026) Table 194. Europe Belladonna Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 195. Europe Belladonna Tablets Sales Market Share Forecast by Country (2027-2032) Table 196. Europe Belladonna Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Europe Belladonna Tablets Market Size by Country (2021-2026) & (US$ Million) Table 198. Europe Belladonna Tablets Market Share by Country (2021-2026) Table 199. Europe Belladonna Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Europe Belladonna Tablets Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Belladonna Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 203. Asia-Pacific Belladonna Tablets Sales Market Share by Country (2021-2026) Table 204. Asia-Pacific Belladonna Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 205. Asia-Pacific Belladonna Tablets Sales Market Share Forecast by Country (2027-2032) Table 206. Asia-Pacific Belladonna Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Asia-Pacific Belladonna Tablets Market Size by Country (2021-2026) & (US$ Million) Table 208. Asia-Pacific Belladonna Tablets Market Share by Country (2021-2026) Table 209. Asia-Pacific Belladonna Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Asia-Pacific Belladonna Tablets Market Share Forecast by Country (2027-2032) Table 211. Latin America Belladonna Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Latin America Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 213. Latin America Belladonna Tablets Sales Market Share by Country (2021-2026) Table 214. Latin America Belladonna Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 215. Latin America Belladonna Tablets Sales Market Share Forecast by Country (2027-2032) Table 216. Latin America Belladonna Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Latin America Belladonna Tablets Market Size by Country (2021-2026) & (US$ Million) Table 218. Latin America Belladonna Tablets Market Share by Country (2021-2026) Table 219. Latin America Belladonna Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Latin America Belladonna Tablets Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Belladonna Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 223. Middle East and Africa Belladonna Tablets Sales Market Share by Country (2021-2026) Table 224. Middle East and Africa Belladonna Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 225. Middle East and Africa Belladonna Tablets Sales Market Share Forecast by Country (2027-2032) Table 226. Middle East and Africa Belladonna Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Middle East and Africa Belladonna Tablets Market Size by Country (2021-2026) & (US$ Million) Table 228. Middle East and Africa Belladonna Tablets Market Share by Country (2021-2026) Table 229. Middle East and Africa Belladonna Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Middle East and Africa Belladonna Tablets Market Share Forecast by Country (2027-2032) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Belladonna Tablets Distributors List Table 234. Belladonna Tablets Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Belladonna Tablets Image Figure 2. Global Belladonna Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Belladonna Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Belladonna Tablets Sales (2021-2032) & (K Units) Figure 5. Compound Preparations Image Figure 6. Global Compound Preparations Sales YoY Growth (2021-2032) & (K Units) Figure 7. Single Preparations Image Figure 8. Global Single Preparations Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Belladonna Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Belladonna Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Belladonna Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Belladonna Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Belladonna Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Belladonna Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Belladonna Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Belladonna Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Belladonna Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Belladonna Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Belladonna Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Belladonna Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Belladonna Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Belladonna Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Belladonna Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Belladonna Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Belladonna Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Belladonna Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Belladonna Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Belladonna Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Belladonna Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Belladonna Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Belladonna Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Belladonna Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Belladonna Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Belladonna Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Belladonna Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Belladonna Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Belladonna Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Belladonna Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Belladonna Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Belladonna Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Belladonna Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Belladonna Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Belladonna Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Belladonna Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Belladonna Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Compound Preparations
  • Single Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  • Yangzhou Aidi Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Wanbangde Pharmaceutical Group Co., Ltd.
  • CSPC Ouyi Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  • Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  • Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  • Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  • Jilin Luwang Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • Jilin Daojun Pharmaceutical Co., Ltd.
  • Henan Baiquan Pharmaceutical Co., Ltd.
  • Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  • Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  • Gansu Lanyao Pharmaceutical Co., Ltd.
  • Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  • Aimin Pharmaceutical Group Co., Ltd.
  • Weleda
  • Raritan Pharmaceuticals
  • Hyland's Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Belladonna Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Belladonna Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Belladonna Tablets Market by Type
  6. 1.3.1 Compound Preparations
  7. 1.3.2 Single Preparations
  8. 1.4 Global Belladonna Tablets Market Size by Type
  9. 1.4.1 Global Belladonna Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Belladonna Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Belladonna Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Belladonna Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Belladonna Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Belladonna Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Belladonna Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Belladonna Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Belladonna Tablets Industry Trends
  2. 2.2 Belladonna Tablets Industry Drivers
  3. 2.3 Belladonna Tablets Industry Opportunities and Challenges
  4. 2.4 Belladonna Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Belladonna Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Belladonna Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Belladonna Tablets Price (2021-2026)
  4. 3.4 Global Belladonna Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Belladonna Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Belladonna Tablets Company, Product Type & Application
  7. 3.7 Global Belladonna Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Belladonna Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Belladonna Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Belladonna Tablets Tier 1, Tier 2, and Tier 3
4 Belladonna Tablets Regional Status and Outlook
  1. 4.1 Global Belladonna Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Belladonna Tablets Historic Market Size by Region
  3. 4.2.1 Global Belladonna Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Belladonna Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Belladonna Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Belladonna Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Belladonna Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Belladonna Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Belladonna Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Belladonna Tablets by Application
  1. 5.1 Belladonna Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Belladonna Tablets Market Size by Application
  6. 5.2.1 Global Belladonna Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Belladonna Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Belladonna Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Belladonna Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Belladonna Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Belladonna Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Belladonna Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Belladonna Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  2. 6.1.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information
  3. 6.1.2 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview
  4. 6.1.3 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio
  6. 6.1.5 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Developments
  7. 6.2 Yangzhou Aidi Pharmaceutical Co., Ltd.
  8. 6.2.1 Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  12. 6.2.5 Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Southwest Pharmaceutical Co., Ltd.
  14. 6.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  18. 6.3.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Wanbangde Pharmaceutical Group Co., Ltd.
  20. 6.4.1 Wanbangde Pharmaceutical Group Co., Ltd. Company Information
  21. 6.4.2 Wanbangde Pharmaceutical Group Co., Ltd. Business Overview
  22. 6.4.3 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  24. 6.4.5 Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments
  25. 6.5 CSPC Ouyi Pharmaceutical Co., Ltd.
  26. 6.5.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  30. 6.5.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Shenyang Tonglian Pharmaceutical Co., Ltd.
  32. 6.6.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  36. 6.6.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  38. 6.7.1 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  42. 6.7.5 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  44. 6.8.1 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  48. 6.8.5 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  50. 6.9.1 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  54. 6.9.5 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  56. 6.10.1 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information
  57. 6.10.2 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview
  58. 6.10.3 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio
  60. 6.10.5 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 6.11 Jilin Luwang Pharmaceutical Co., Ltd.
  62. 6.11.1 Jilin Luwang Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  66. 6.11.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Jilin Hengjin Pharmaceutical Co., Ltd.
  68. 6.12.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  72. 6.12.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jilin Daojun Pharmaceutical Co., Ltd.
  74. 6.13.1 Jilin Daojun Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Jilin Daojun Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  78. 6.13.5 Jilin Daojun Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Henan Baiquan Pharmaceutical Co., Ltd.
  80. 6.14.1 Henan Baiquan Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Henan Baiquan Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  84. 6.14.5 Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  86. 6.15.1 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  90. 6.15.5 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  92. 6.16.1 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  96. 6.16.5 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Gansu Lanyao Pharmaceutical Co., Ltd.
  98. 6.17.1 Gansu Lanyao Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  102. 6.17.5 Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  104. 6.18.1 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  108. 6.18.5 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Aimin Pharmaceutical Group Co., Ltd.
  110. 6.19.1 Aimin Pharmaceutical Group Co., Ltd. Company Information
  111. 6.19.2 Aimin Pharmaceutical Group Co., Ltd. Business Overview
  112. 6.19.3 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  114. 6.19.5 Aimin Pharmaceutical Group Co., Ltd. Recent Developments
  115. 6.20 Weleda
  116. 6.20.1 Weleda Company Information
  117. 6.20.2 Weleda Business Overview
  118. 6.20.3 Weleda Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Weleda Belladonna Tablets Product Portfolio
  120. 6.20.5 Weleda Recent Developments
  121. 6.21 Raritan Pharmaceuticals
  122. 6.21.1 Raritan Pharmaceuticals Company Information
  123. 6.21.2 Raritan Pharmaceuticals Business Overview
  124. 6.21.3 Raritan Pharmaceuticals Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Raritan Pharmaceuticals Belladonna Tablets Product Portfolio
  126. 6.21.5 Raritan Pharmaceuticals Recent Developments
  127. 6.22 Hyland's Inc
  128. 6.22.1 Hyland's Inc Company Information
  129. 6.22.2 Hyland's Inc Business Overview
  130. 6.22.3 Hyland's Inc Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Hyland's Inc Belladonna Tablets Product Portfolio
  132. 6.22.5 Hyland's Inc Recent Developments
7 North America by Country
  1. 7.1 North America Belladonna Tablets Sales by Country
  2. 7.1.1 North America Belladonna Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Belladonna Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Belladonna Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Belladonna Tablets Market Size by Country
  6. 7.2.1 North America Belladonna Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Belladonna Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Belladonna Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Belladonna Tablets Sales by Country
  2. 8.1.1 Europe Belladonna Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Belladonna Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Belladonna Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Belladonna Tablets Market Size by Country
  6. 8.2.1 Europe Belladonna Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Belladonna Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Belladonna Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Belladonna Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Belladonna Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Belladonna Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Belladonna Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Belladonna Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Belladonna Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Belladonna Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Belladonna Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Belladonna Tablets Sales by Country
  2. 10.1.1 South America Belladonna Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Belladonna Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Belladonna Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Belladonna Tablets Market Size by Country
  6. 10.2.1 South America Belladonna Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Belladonna Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Belladonna Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Belladonna Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Belladonna Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Belladonna Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Belladonna Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Belladonna Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Belladonna Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Belladonna Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Belladonna Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Belladonna Tablets Value Chain Analysis
  2. 12.1.1 Belladonna Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Belladonna Tablets Production Mode & Process
  7. 12.2 Belladonna Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Belladonna Tablets Distributors
  10. 12.2.3 Belladonna Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst